Skip to content
Disclosery

EXANE DERIVATIVES: BMRN position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on BMRN, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 1,473 BMRN shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 1,473 shares
    Change vs previous 13F -416 shares

    0.07% of the 13F portfolio, value $122,055.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 1,889 shares
    Change vs previous 13F -220 shares

    0.04% of the 13F portfolio, value $145,636.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 2,109 shares
    Change vs previous 13F -667 shares

    0.05% of the 13F portfolio, value $186,328.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 2,776 shares
    Change vs previous 13F -293 shares

    0.05% of the 13F portfolio, value $214,554.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 3,069 shares
    Change vs previous 13F +233 shares

    0.06% of the 13F portfolio, value $250,121.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 2,836 shares
    Change vs previous 13F +978 shares

    0.06% of the 13F portfolio, value $214,143.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 1,858 shares
    Change vs previous 13F +1,130 shares

    0.05% of the 13F portfolio, value $162,925.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 728 shares
    Change vs previous 13F not available

    0.02% of the 13F portfolio, value $55,384.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).